首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   4210篇
  免费   222篇
  国内免费   26篇
耳鼻咽喉   38篇
儿科学   78篇
妇产科学   93篇
基础医学   571篇
口腔科学   71篇
临床医学   521篇
内科学   826篇
皮肤病学   55篇
神经病学   458篇
特种医学   195篇
外科学   750篇
综合类   17篇
一般理论   2篇
预防医学   189篇
眼科学   150篇
药学   255篇
肿瘤学   189篇
  2023年   31篇
  2022年   47篇
  2021年   78篇
  2020年   58篇
  2019年   73篇
  2018年   80篇
  2017年   75篇
  2016年   101篇
  2015年   94篇
  2014年   135篇
  2013年   182篇
  2012年   244篇
  2011年   219篇
  2010年   157篇
  2009年   147篇
  2008年   218篇
  2007年   242篇
  2006年   219篇
  2005年   218篇
  2004年   193篇
  2003年   221篇
  2002年   236篇
  2001年   112篇
  2000年   88篇
  1999年   73篇
  1998年   65篇
  1997年   70篇
  1996年   36篇
  1995年   29篇
  1994年   28篇
  1993年   27篇
  1992年   45篇
  1991年   33篇
  1990年   52篇
  1989年   39篇
  1988年   28篇
  1987年   26篇
  1986年   26篇
  1985年   24篇
  1984年   24篇
  1983年   28篇
  1982年   17篇
  1979年   26篇
  1978年   21篇
  1977年   19篇
  1975年   16篇
  1974年   17篇
  1973年   17篇
  1972年   23篇
  1971年   17篇
排序方式: 共有4458条查询结果,搜索用时 15 毫秒
1.
Interferon-alpha (IFN-alpha) has proved effective in the treatment of hemangiomas, hemangioblastomas, and Kaposi's sarcoma. To investigate the ability of IFNs to inhibit angiosarcoma, we used two transformed murine endothelial cell lines that form angiosarcomas in vivo. SVR and MS1-VEGF cell lines express oncogenic H-ras or vascular endothelial growth factor (VEGF), respectively. IFN-alpha1,8, which is active against murine and human cells, inhibited SVR and MS1-VEGF proliferation in vitro by 40% at 10(3) U/mL (p = 0.028). In vivo, IFN-alpha1,8 inhibited SVR tumor volume by 71% (p = 0.047) and MS1-VEGF volume by 79% (p = 0.003). Tumor-induced angiogenesis was decreased in SVR tumors by 52% (p = 0.005) and in MS1-VEGF tumors by 58% (p = 0.001). Sera from IFN-alpha1,8-treated mice bearing either SVR or MS1-VEGF tumors demonstrated a 5-fold increase in IP-10/CXCL10 (p = 0.001), an IFN-induced antiangiogenic protein. Both recombinant IP-10 and IFN-alpha1,8 inhibited human umbilical vein endothelial cell (HUVEC) vessel formation in the fibrin gel assay, a three-dimensional culture model of angiogenesis, by 56% at 25 ng/mL and 50% at 1.2 ng/mL, respectively (p < 0.001). An IP-10 blocking antibody restored vessel formation to 80% of untreated controls (p = 0.001). Given the magnitude of the in vivo response, these data suggested that the antitumor effects of IFN-alpha1,8 were likely mediated through angiogenesis inhibition rather than solely by direct inhibition of tumor cell proliferation.  相似文献   
2.
3.
4.
The objective of this review is to identify and review publications describing the impact of reduced somatosensation on balance. Based on knowledge of the association between specific somatosensory loss and deterioration of balance, conclusions can be made about role of somatosensation in standing balance.A systematic literature review is presented in which publications from the years 1993 through 2007 were searched in Medline and Embase. Medical Subject Headings (MESH) terms and free text words (related to balance, somatosensory loss, and lower limb) were used to perform the searches. Fifteen articles were selected for detailed review based on predetermined inclusion criteria, and three of the included articles described the effect of experimentally reduced somatosensation on balance in healthy subjects. Ten of the articles described balance in diabetic neuropathy (DN). The last two included articles described balance in Charcot-Marie-Tooth (CMT) disease type 1A (CMT1A) or type 2 (CMT2).The literature indicates that the tactile sensation is reduced in DN, CMT1A, and CMT2 and when the plantar surface of the feet was hypothermically anesthetized. Joint motion sensation seems to be impaired in patients with DN, and passive joint position sensation appears to be reduced in healthy subjects with anesthesia of ankle and foot from prolonged ischemia. This reduced somatosensation seems to have a negative effect on balance in patients with DN and CMT2; however, this appeared not to be the case in patients with CMT1A and in healthy subjects.  相似文献   
5.
Evidence of the effect of exercise on bone loss comes mainly from studies in voluntary postmenopausal women, and no population-based, long-term interventions have been performed. The purpose of this population-based, randomized, controlled trial was to determine the effect of long-term impact exercise on bone mass at various skeletal sites in elderly women with low bone mineral density (BMD) at the radius and hip. Participants ( n =160) were randomly assigned to 30 months either of supervised and home-based impact exercise training or of no intervention. The primary outcome measures were femoral neck, trochanter and total hip BMD, and the secondary outcomes were bone density measures at the radius and calcaneum. Outcomes were assessed at baseline, 12 months and 30 months using blinded operators. The analyses were performed on an intention-to-treat analysis. Mean femoral neck and trochanter BMD decreased in the control group [–1.1%, 95% confidence interval (CI) –0.1% to –2.1% and –1.6%, 95% CI –0.4% to –2.7%], while no change occurred in the exercise group. Mean trochanter BMC decreased more in the control group (–7.7%, 95% CI –9.7% to –5.6% vs. –2.9%, 95% CI –5.3 to –0.9). There were six falls that resulted in fractures in the exercise group and 16 in the control group during the 30-month intervention ( P =0.019). A significant bone loss occurred in both groups at the radius and calcaneum. In multivariate analysis, weight gain was associated with increased BMD and BMC at all femur sites both in the exercise group and in the pooled groups. In conclusion, impact exercise had no effect on BMD, while there was a positive effect on BMC at the trochanter. Exercise may prevent fall-related fractures in elderly women with low bone mass.There was no conflict of interest.  相似文献   
6.
7.
8.
Local hyperthermia of the prostate was used to treat 72 patients who had an indwelling catheter because of urinary retention caused by benign prostatic hypertrophy. One month after completion of treatment 50% of patients were able to dispense with the catheter and 1 year later 40% remained catheter-free. The best results were achieved in patients who underwent 6 to 10 treatment sessions in conjunction with cyproterone acetate 50 mg tid administered during the treatment period only.  相似文献   
9.
Since we introduced angioscopy in autumn 1991 byin situ vein bypass operations we have used four different angioscopes with outer diameters of 2.2, 2.3, 2.8, and 2.9 mm. The 2.2 mm model was steerable, and collateral irrigation through a separate irrigation catheter was used. The other scopes had a built-in irrigation channel. Irrigation fluid was provided by a pressure cuff device placed around a liter of Ringer's acetate solution in plastic bag and inflated to between 200 and 300 mmHg. Recently we have used a roller pump that provides adjustment of the flow rate with a constant pressure of 200 mmHg. A Mills valve cutter was tested in the initial phase, but later the Insitucath proved more suitable. Valve disruption has been safe and confident. In addition, the angioscopy has been used as an adjuvant method in carotid endartectomies, thromboembolectomies, aortobifemoral reconstructions, iliacofemoral endarterectomies, in vascular access surgery, and percutaneous stent application. The visualization has been excellent or good and there have not been any significant complications due to the angioscopes. The use of angioscopy is well established in our arterial procedures and in the near future it will be introduced in venous surgery. The need for further studies concerning the significance of intraluminal findings is obvious.Presented at the 35th World Congress, International College of Angiology, Copenhagen, Denmark, July 1993  相似文献   
10.
Objective: To study tubal patency and fertility outcome of patients with expectantly managed ectopic pregnancy (EP).

Design: A prospective study.

Setting: Department of Obstetrics and Gynecology, Turku University Central Hospital, Turku, Finland.

Patient(s): Thirty patients who wanted to become pregnant again were treated successfully by expectant management of EP.

Intervention(s): Patients were examined with posttreatment hysterosalpingography, and they filled out a questionnaire about their subsequent pregnancies.

Main Outcome Measure(s): Free passage through open lumen showing tubal patency; number of full-term pregnancies and EPs revealing relative rate of subsequent fertility.

Result(s): A free passage through the diseased tube was seen in 93% of the cases (28 of 30). Two of the 24 patients (8.4%) who wanted to become pregnant had an obstruction in the diseased tube. One (4.2%) of them had a normal opposite tube and later had a normal pregnancy. The other (4.2%) had an obstruction in both tubes and subsequently had a repeat EP. One of the 6 patients had an EP (this patient did not want to become pregnant and did not use contraception). However, her posttreatment hysterosalpingography was normal. In total, the subsequent pregnancy rate was 88% (21 of 24), and the rate of repeat EP was 4.2% (1 of 24).

Conclusion(s): Patients who are treated with expectant management have a good long-term fertility outcome. Spontaneous regression of EP does not lead to increased harm or damage to the tube, i.e., the risk for repeat EP is low.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号